They also highlight that lab variability in testing AMH can generate disparate results, making it difficult to compare such findings
NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) studyA randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC)
Dziaanie peptydu na ten ukad poparte jest badaniami i dowodami, ktre wiadcz o tym, i systematyczne i regularne stosowanie BPC-157 wpywa pozytywnie na ten ukad
In vivo recordings : chronic electrodes in CA1 to measure theta/gamma oscillations, sharp-wave-ripples (mnemonic replay)
Ribechini E, Hutchinson JA, Hergovits S, Heuer M, Lucas J, Schleicher U, Jordn Garrote AL, Potter SJ, Riquelme P, Brackmann H, Mller N, Raifer H, Berberich I, Huber M, Beilhack A, Lohoff M, Bogdan C, Eyrich M, Hermanns HM, Geissler EK, Lutz MB
